Publications
2 shownHallmarks of response, resistance, and toxicity to immune checkpoint blockade
Unprecedented advances have been made in cancer treatment with the use of immune checkpoint blockade (ICB). However, responses are limited to a subset of patients, and immune-re...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 3,857
- Institution
- The University of Texas MD Anderson Cancer Center
External Links
Identifiers
- ORCID
- 0000-0002-8206-0351
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.